Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2009, Article ID 394021, 8 pages
http://dx.doi.org/10.1155/2009/394021
Research Article

IL-4 Deficiency Decreases Mortality but Increases Severity of Arthritis in Experimental Group B Streptococcus Infection

Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Via del Giochetto, 06122 Perugia, Italy

Received 28 January 2009; Accepted 23 April 2009

Academic Editor: Vera L. Petricevich

Copyright © 2009 Luciana Tissi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Schuchat, “Group B streptococcus,” The Lancet, vol. 353, no. 9146, pp. 51–56, 1999. View at Publisher · View at Google Scholar
  2. M. A. Krohn, S. L. Hillier, and C. J. Baker, “Maternal peripartum complications associated with vaginal group B streptococci colonization,” The Journal of Infectious Diseases, vol. 179, no. 6, pp. 1410–1415, 1999. View at Publisher · View at Google Scholar
  3. S. J. Schrag, S. Zywicki, M. M. Farley et al., “Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis,” The New England Journal of Medicine, vol. 342, no. 1, pp. 15–20, 2000. View at Publisher · View at Google Scholar
  4. L. A. Jackson, R. Hilsdon, M. M. Farley et al., “Risk factors for group B streptococcal disease in adults,” Annals of Internal Medicine, vol. 123, no. 6, pp. 415–420, 1995. View at Google Scholar
  5. O. Perovic, H. H. Crewe-Brown, M. Khoosal, and A. S. Karstaedt, “Invasive group B streptococcal disease in nonpregnant adults,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 18, no. 5, pp. 362–364, 1999. View at Publisher · View at Google Scholar
  6. M. M. Farley, “Group B streptococcal disease in nonpregnant adults,” Clinical Infectious Diseases, vol. 33, no. 4, pp. 556–561, 2001. View at Publisher · View at Google Scholar
  7. J. M. Colford Jr., J. Mohle-Boetani, and K. L. Vosti, “Group B streptococcal bacteremia in adults: five years' experience and a review of the literature,” Medicine, vol. 74, no. 4, pp. 176–190, 1995. View at Publisher · View at Google Scholar
  8. J. M. Garcia-Lechuz, P. Bachiller, F. J. Vasallo, P. Munoz, B. Padilla, and E. Bouza, “Group B streptococcal osteomyelitis in adults,” Medicine, vol. 78, no. 3, pp. 191–199, 1999. View at Publisher · View at Google Scholar
  9. M. A. Gardam, D. E. Low, R. Saginur, and M. A. Miller, “Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults,” Archives of Internal Medicine, vol. 158, no. 15, pp. 1704–1708, 1998. View at Publisher · View at Google Scholar
  10. J. L. Esterhai Jr. and I. Gelb, “Adult septic arthritis,” Orthopedic Clinics of North America, vol. 22, no. 3, pp. 503–514, 1991. View at Google Scholar
  11. D. L. Goldenberg and J. I. Reed, “Bacterial arthritis,” The New England Journal of Medicine, vol. 312, no. 12, pp. 764–771, 1985. View at Google Scholar
  12. I. S. Mikhail and G. S. Alarcon, “Nongonococcal bacterial arthritis,” Rheumatic Disease Clinics of North America, vol. 19, no. 2, pp. 311–331, 1993. View at Google Scholar
  13. A. S. Bayer, A. W. Chow, B. F. Anthony, and L. B. Guze, “Serious infections in adults due to group B streptococci: clinical and serotypic characterization,” The American Journal of Medicine, vol. 61, no. 4, pp. 498–503, 1976. View at Publisher · View at Google Scholar
  14. P. Lerner, K. V. Gopalakrishna, E. Wolinsky, M. C. McHenry, J. S. Tan, and M. Rosenthal, “Group B streptococcus (S. agalactiae) bacteremia in adults: analysis of 32 cases and review of the literature,” Medicine, vol. 56, no. 6, pp. 457–473, 1977. View at Publisher · View at Google Scholar
  15. C. B. Small, L. N. Slater, F. D. Lowy, R. D. Small, E. A. Salvati, and J. I. Casey, “Group B streptococcal arthritis in adults,” The American Journal of Medicine, vol. 76, no. 3, pp. 367–375, 1984. View at Publisher · View at Google Scholar
  16. A. J. Laster and M. L. Michels, “Group B streptococcus arthritis in adults,” The American Journal of Medicine, vol. 76, no. 5, pp. 910–915, 1984. View at Publisher · View at Google Scholar
  17. J. M. Nolla, C. Gómez-Vaquero, X. Corbella et al., “Group B streptococcus (Streptococcus agalactiae) pyogenic arthritis in nonpregnant adults,” Medicine, vol. 82, no. 2, pp. 119–128, 2003. View at Publisher · View at Google Scholar
  18. J.-J. Dubost, M. Soubrier, C. De Champs, J.-M. Ristori, and B. Sauvezie, “Streptococcal septic arthritis in adults. A study of 55 cases with a literature review,” Joint Bone Spine, vol. 71, no. 4, pp. 303–311, 2004. View at Publisher · View at Google Scholar
  19. L. Tissi, P. Marconi, P. Mosci et al., “Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis,” Infection and Immunity, vol. 58, no. 9, pp. 3093–3100, 1990. View at Google Scholar
  20. L. Tissi, “Experimental group B Streptococcus arthritis in mice,” in Handbook of Animal Models of Infection, O. Zak and M. Sande, Eds., chapter 65, pp. 549–559, Academic Press, London, UK, 1999. View at Google Scholar
  21. L. Tissi, C. von Hunolstein, F. Bistoni, M. Marangi, L. Parisi, and G. Orefici, “Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis,” Journal of Medical Microbiology, vol. 47, no. 8, pp. 717–723, 1998. View at Google Scholar
  22. M. Puliti, V. Nizet, C. von Hunolstein et al., “Severity of group B streptococcal arthritis is correlated with ß-hemolysin expression,” The Journal of Infectious Diseases, vol. 182, no. 3, pp. 824–832, 2000. View at Publisher · View at Google Scholar
  23. M. Puliti, C. von Hunolstein, F. Bistoni, P. Mosci, G. Orefici, and L. Tissi, “Influence of interferon-γ administration on the severity of experimental group B streptococcal arthritis,” Arthritis & Rheumatism, vol. 43, no. 12, pp. 2678–2686, 2000. View at Publisher · View at Google Scholar
  24. M. Puliti, C. von Hunolstein, F. Bistoni, R. Castronari, G. Orefici, and L. Tissi, “Role of macrophages in experimental group B streptococcal arthritis,” Cellular Microbiology, vol. 4, no. 10, pp. 691–700, 2002. View at Publisher · View at Google Scholar
  25. L. Tissi, M. Puliti, R. Barluzzi, G. Orefici, C. von Hunolstein, and F. Bistoni, “Role of tumor necrosis factor alpha, interleukin-1β, and interleukin-6 in a mouse model of group B streptococcal arthritis,” Infection and Immunity, vol. 67, no. 9, pp. 4545–4550, 1999. View at Google Scholar
  26. A. A. te Velde, R. J. F. Huijbens, K. Heije, J. E. de Vries, and C. G. Figdor, “Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor α, and IL-6 by human monocytes,” Blood, vol. 76, no. 7, pp. 1392–1397, 1990. View at Google Scholar
  27. A. Finnegan, M. J. Grusby, C. D. Kaplan et al., “IL-4 and IL-12 regulate proteoglycan-induced arthritis through stat-dependent mechanisms,” The Journal of Immunology, vol. 169, no. 6, pp. 3345–3352, 2002. View at Google Scholar
  28. T. J. Standiford, R. M. Strieter, S. W. Chensue, J. Westwick, K. Kasahara, and S. L. Kunkel, “IL-4 inhibits the expression of IL-8 from stimulated human monocytes,” The Journal of Immunology, vol. 145, no. 5, pp. 1435–1439, 1990. View at Google Scholar
  29. S. C. Gautam, N. F. Chikkala, and T. A. Hamilton, “Anti-inflammatory action of IL-4: negative regulation of contact sensitivity to trinitrochlorobenzene,” The Journal of Immunology, vol. 148, no. 5, pp. 1411–1415, 1992. View at Google Scholar
  30. A. C. Horsfall, D. M. Butler, L. Marinova et al., “Suppression of collagen-induced arthritis by continuous administration of IL-4,” The Journal of Immunology, vol. 159, no. 11, pp. 5687–5696, 1997. View at Google Scholar
  31. A. Finnegan, K. Mikecz, P. Tao, and T. T. Glant, “Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines,” The Journal of Immunology, vol. 163, no. 10, pp. 5383–5390, 1999. View at Google Scholar
  32. E. Lubberts, L. A. B. Joosten, L. van den Bersselaar et al., “Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction,” The Journal of Immunology, vol. 163, no. 8, pp. 4546–4556, 1999. View at Google Scholar
  33. L. A. B. Joosten, E. Lubberts, M. M. A. Helsen et al., “Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis,” Arthritis Research, vol. 1, no. 1, pp. 81–91, 1999. View at Publisher · View at Google Scholar
  34. M. Kopf, G. Le Gros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Kohler, “Disruption of the murine IL-4 gene blocks Th2 cytokine responses,” Nature, vol. 362, no. 6417, pp. 245–248, 1993. View at Publisher · View at Google Scholar
  35. J. A. Smith, “Neutrophils, host defense, and inflammation: a double-edged sword,” Journal of Leukocyte Biology, vol. 56, no. 6, pp. 672–686, 1994. View at Google Scholar
  36. L. Tissi, B. McRae, T. Ghayur et al., “Role of interleukin-18 in experimental group B streptococcal arthritis,” Arthritis & Rheumatism, vol. 50, no. 6, pp. 2005–2013, 2004. View at Publisher · View at Google Scholar
  37. O. Hultgren, M. Kopf, and A. Tarkowski, “Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth,” The Journal of Immunology, vol. 160, no. 10, pp. 5082–5087, 1998. View at Google Scholar
  38. J. L. Ho, S. H. He, M. J. C. Rios, and E. A. Wick, “Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity,” The Journal of Infectious Diseases, vol. 165, no. 2, pp. 344–351, 1992. View at Google Scholar
  39. E. Cenci, L. Romani, A. Mencacci et al., “Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans,” European Journal of Immunology, vol. 23, no. 5, pp. 1034–1038, 1993. View at Publisher · View at Google Scholar
  40. S. Yoshino, “Effect of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice,” British Journal of Pharmacology, vol. 123, no. 2, pp. 237–242, 1998. View at Publisher · View at Google Scholar
  41. J. B. Allen, H. L. Wong, G. L. Costa, M. J. Bienkowski, and S. M. Wahl, “Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis,” The Journal of Immunology, vol. 151, no. 8, pp. 4344–4351, 1993. View at Google Scholar
  42. J. Zwerina, K. Redlich, G. Schett, and J. S. Smolen, “Pathogenesis of rheumatoid arthritis: targeting cytokines,” Annals of the New York Academy of Sciences, vol. 1051, pp. 716–729, 2005. View at Publisher · View at Google Scholar
  43. M. Chabaud, J. M. Durand, N. Buchs et al., “Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium,” Arthritis & Rheumatism, vol. 42, no. 5, pp. 963–970, 1999. View at Publisher · View at Google Scholar
  44. Z. Szekanecz and A. E. Koch, “Chemokines and angiogenesis,” Current Opinion in Rheumatology, vol. 13, no. 3, pp. 202–208, 2001. View at Publisher · View at Google Scholar
  45. M. Kobayashi, G. R. Squires, A. Mousa et al., “Role of interleukin-1 and tumor necrosis factor a in matrix degradation of human osteoarthritic cartilage,” Arthritis & Rheumatism, vol. 52, no. 1, pp. 128–135, 2005. View at Publisher · View at Google Scholar
  46. S. Kotake, N. Udagawa, N. Takahashi et al., “IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis,” The Journal of Clinical Investigation, vol. 103, no. 9, pp. 1345–1352, 1999. View at Publisher · View at Google Scholar